Melek Tugce Yilmaz, Instructor of Radiation Oncology at Hacettepe University, shared a post on X:
”Real-world evidence for SBRT in oligometastatic disease! Interim analysis of the ESTRO-EORTC OligoCare cohort presented at ESTRO26 showed durable local control outcomes in more than 2400 patients treated with SBRT.”
Other Articles On OncoDaily.
